Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer
Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer
Two molecular targets-human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)-are highly promising candidates for…
Platelets found to mop up DNA fragments and improve early cancer detection
Platelets are probably best known for their role in blood clotting, making scabs and related, if less salubrious,…
Genomic clues uncover early origins of multiple myeloma
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…
Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma
A new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipulation of the…
Tumor microbiota identified as predictors of prognosis in gastrointestinal cancers
Microbes inside cancerous tumors can influence the spread of disease and the effectiveness of treatment. Those roles make…
Diabetes-altered blood particles suppress immune defense in breast cancer
People with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no one knows exactly…
Why ‘Zombie Squirrels’ Have Been Appearing In The U.S. And Canada
News of “zombie squirrels” appearing in the U.S. and Canada may be a bit shocking to squirrels and…
SOX2 drives progression and therapy resistance in advanced prostate cancer
Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…
New study uncovers a surprising mechanism of resistance to immunotherapy
A new international study led by researchers at Moffitt Cancer Center, the Karolinska Institutet and the University of…